Functional Roles of Pigment Epithelium-Derived Factor in Retinal Degenerative and Vascular Disorders: A Scoping Review
Investigative Ophthalmology & Visual Science · 2024-12-27 · 65 (14) · 41
DOI: 10.1167/iovs.65.14.41 ↗At a glance
Scoping Review in Investigative Ophthalmology & Visual Science, published on 2024-12-27. Written by Thomas Stax Jakobsen and 3 co-authors. Institution: Department of Biomedicine, Aarhus University, Aarhus C, Denmark. Major MEDLINE topics: Serpins, Nerve Growth Factors, Eye Proteins. Cited 21 times so far (Crossref); 204 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
This review explores the role of pigment epithelium-derived factor (PEDF) in retinal degenerative and vascular disorders and assesses its potential both as an adjunct to established vascular endothelial growth factor inhibiting treatments for retinal vascular diseases and as a neuroprotective therapeutic agent.
Methods
A comprehensive literature review was conducted, focusing on the neuroprotective and anti-angiogenic properties of PEDF. The review evaluated its effects on retinal health, its dysregulation in ocular disorders, and its therapeutic application in preclinical models. Advances in drug delivery, including gene therapy, were also examined.
Results
PEDF, initially identified for promoting neuronal differentiation, is also a potent endogenous angiogenesis inhibitor. Strong anti-angiogenic and neuroprotective effects are observed in preclinical studies. It has pro-apoptotic and antiproliferative effects on endothelial cells thereby reducing neovascularization. Although promising, clinical development is limited with only a single conducted phase I clinical trial for macular neovascularization. Development of PEDF-derived peptides enhances potency and specificity, and emerging gene therapy approaches offer sustained PEDF expression for long-term treatment. However, questions regarding dosage, durability, and efficacy remain, particularly in large animal models.
Conclusions
PEDF shows significant therapeutic potential in preclinical models of retinal degeneration and vascular disorders. Despite inconclusive evidence on PEDF downregulation as a primary disease driver, many studies highlight its therapeutic benefits and favorable safety profile. Advances in gene therapy could enable long-acting PEDF-based treatments, but further research is needed to optimize dosage and durability, potentially leading to clinical trials and expanding treatment options for retinal disorders.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Biomedicine, Aarhus University, Aarhus C, Denmark.
- Department of Ophthalmology, Aarhus University Hospital, Aarhus N, Denmark.
Cite
APA
Jakobsen, T. S., Adsersen, R. L., Askou, A. L., & Corydon, T. J. (2024). Functional Roles of Pigment Epithelium-Derived Factor in Retinal Degenerative and Vascular Disorders: A Scoping Review. Investigative Ophthalmology & Visual Science, 65(14), 41. https://doi.org/10.1167/iovs.65.14.41
Vancouver
Jakobsen TS, Adsersen RL, Askou AL, Corydon TJ. Functional Roles of Pigment Epithelium-Derived Factor in Retinal Degenerative and Vascular Disorders: A Scoping Review. Investigative Ophthalmology & Visual Science. 2024;65(14):41. doi:10.1167/iovs.65.14.41
BibTeX
@article{Jakobsen2024,
author = {Jakobsen, Thomas Stax and Adsersen, Rikke L and Askou, Anne Louise and Corydon, Thomas J},
title = {Functional Roles of Pigment Epithelium-Derived Factor in Retinal Degenerative and Vascular Disorders: A Scoping Review},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
volume = {65},
number = {14},
pages = {41},
doi = {10.1167/iovs.65.14.41}
}
EUVIMED